← All stocks

Corvus Pharmaceuticals, Inc.

CRVS Balanced
CIK 0001626971 #2415 in the set updated 18 Sep 2026
Bought (120 mo)
$48.97M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$62.61M
$0.00 on a plan · $9.78M straight out of an exercise
Sold at will
$52.82M
9 of 11 sales
Net
−$13.64M
−$3.86M against sales at will

By person

13 insiders · 101 transactions

There is no salary here to measure against. Corvus Pharmaceuticals, Inc.'s chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
EcoR1 Capital, LLC entity
10% owner
$25.06M (2)
−$25.06M
81,077
0.0964%
$934.95K
−98.4%
ADAMS STREET PARTNERS LLC entity
10% owner
$5.00M (5)
+$5.00M
3,402,422
4.04%
$39.24M
+20.9%
Gould Terry P
Director
$5.00M (5)
+$5.00M
3,402,422
4.04%
$39.24M
+20.9%
Novo Holdings A/S entity
10% owner
$10.22M (2)
$14.25M (5)
−$4.03M
1,389,498
1.65%
$16.02M
−56.9%
MILLER RICHARD A MD
President and CEO
$3.24M (40)
+$3.24M
3,620,257
4.30%
$41.75M
+59.8%
ORBIMED ADVISORS LLC entity
Director
$12.44M (6)
$11.65M (2)
+$795.16K
15,218,304
18.09%
$175.49M
+13.3%
Thompson Peter A.
Director
$12.44M (6)
$11.65M (2)
+$795.16K
15,428,304
18.34%
$177.91M
+14.9%
LEA LEIV
Chief Financial Officer
$294.07K (7)
+$294.07K
332,644
0.3954%
$3.84M
+66.8%
Moore David Scott
Director
$250.24K (1)
+$250.24K
21,700
0.0258%
$250.24K
Jones William Benton
See Remarks
$50.42K (2)
+$50.42K
173,130
0.2058%
$2.00M
+52.2%
Grais Linda
Director
$24.50K (1)
+$24.50K
10,000
0.0119%
$115.32K
Buggy Joseph J
EVP, Discovery Research
351,186
0.4175%
$4.05M
0.0%
Verner Erik J.
VP, Chemistry Research
63,773
0.0758%
$735.40K
0.0%
Insider
Date
Role
Action
Shares
Price
Amount
Moore David Scott
11 Jun 2026
Director
Buy
21,700
$11.53
$250.24K
MILLER RICHARD A MD
18 May 2026
President and CEO
Buy indirect
1,932
$12.01
$23.20K
MILLER RICHARD A MD
18 May 2026
President and CEO
Buy indirect
5,000
$12.05
$60.25K
MILLER RICHARD A MD
6 May 2024
President and CEO
Buy
577,634
$1.73
$1,000.00K
Jones William Benton
6 May 2024
See Remarks
Buy
20,000
$1.73
$34.62K
Grais Linda
15 May 2023
Director
Buy
10,000
$2.45
$24.50K
Jones William Benton
20 Dec 2022
See Remarks
Buy
20,000
$0.79
$15.80K
MILLER RICHARD A MD
14 Dec 2022
President and CEO
Buy indirect
10,000
$0.78
$7.81K
LEA LEIV
14 Dec 2022
Chief Financial Officer
Buy indirect
4,000
$0.84
$3.36K
MILLER RICHARD A MD
13 Dec 2022
President and CEO
Buy indirect
50,000
$0.74
$37.02K
LEA LEIV
13 Dec 2022
Chief Financial Officer
Buy indirect
30,000
$0.74
$22.28K
MILLER RICHARD A MD
28 Sep 2022
President and CEO
Buy indirect
25,000
$0.76
$19.07K
MILLER RICHARD A MD
20 Sep 2022
President and CEO
Buy indirect
5,000
$0.82
$4.08K
MILLER RICHARD A MD
20 Sep 2022
President and CEO
Buy indirect
2,700
$0.82
$2.21K
MILLER RICHARD A MD
20 Sep 2022
President and CEO
Buy indirect
12,300
$0.81
$9.96K
MILLER RICHARD A MD
27 Jun 2022
President and CEO
Buy indirect
5,000
$1.00
$4.98K
MILLER RICHARD A MD
24 Jun 2022
President and CEO
Buy indirect
5,000
$1.03
$5.15K
MILLER RICHARD A MD
6 Jun 2022
President and CEO
Buy indirect
890
$1.01
$898.90
MILLER RICHARD A MD
2 Jun 2022
President and CEO
Buy indirect
170
$0.97
$164.90
MILLER RICHARD A MD
2 Jun 2022
President and CEO
Buy indirect
4,830
$0.98
$4.73K
MILLER RICHARD A MD
31 Mar 2022
President and CEO
Buy indirect
15,000
$1.64
$24.53K
MILLER RICHARD A MD
17 Mar 2022
President and CEO
Buy indirect
5,000
$1.59
$7.95K
LEA LEIV
17 Mar 2022
Chief Financial Officer
Buy indirect
13,878
$1.65
$22.90K
LEA LEIV
16 Mar 2022
Chief Financial Officer
Buy indirect
35,160
$1.54
$54.15K
MILLER RICHARD A MD
15 Mar 2022
President and CEO
Buy indirect
25,000
$1.47
$36.65K
MILLER RICHARD A MD
20 Aug 2021
President and CEO
Buy indirect
10,000
$1.93
$19.25K
MILLER RICHARD A MD
4 May 2021
President and CEO
Buy
35,714
$2.80
$100.00K
MILLER RICHARD A MD
17 Feb 2021
President and CEO
Buy indirect
100,000
$3.50
$350.00K
Thompson Peter A.
17 Feb 2021
Director
Buy indirect
1,285,714
$3.50
$4.50M
ORBIMED ADVISORS LLC
17 Feb 2021
Director
Buy indirect
1,285,714
$3.50
$4.50M
MILLER RICHARD A MD
13 Nov 2019
President and CEO
Buy indirect
14,736
$3.00
$44.24K
MILLER RICHARD A MD
12 Nov 2019
President and CEO
Buy indirect
272
$2.90
$788.80
MILLER RICHARD A MD
7 Aug 2019
President and CEO
Buy indirect
2,500
$3.54
$8.85K
MILLER RICHARD A MD
6 Aug 2019
President and CEO
Buy indirect
5,000
$3.58
$17.88K
ORBIMED ADVISORS LLC
6 Aug 2019
Director
Buy indirect
142,656
$3.51
$500.72K
Thompson Peter A.
6 Aug 2019
Director
Buy indirect
142,656
$3.51
$500.72K
ORBIMED ADVISORS LLC
1 Jul 2019
Director
Buy indirect
59,243
$3.91
$231.64K
Thompson Peter A.
1 Jul 2019
Director
Buy indirect
59,243
$3.91
$231.64K
ORBIMED ADVISORS LLC
28 Jun 2019
Director
Buy indirect
565,178
$3.72
$2.10M
Thompson Peter A.
28 Jun 2019
Director
Buy indirect
565,178
$3.72
$2.10M
ORBIMED ADVISORS LLC
27 Jun 2019
Director
Buy indirect
32,923
$3.34
$109.96K
Thompson Peter A.
27 Jun 2019
Director
Buy indirect
32,923
$3.34
$109.96K
MILLER RICHARD A MD
14 Jun 2019
President and CEO
Buy indirect
11,657
$3.40
$39.67K
MILLER RICHARD A MD
13 Jun 2019
President and CEO
Buy indirect
343
$3.52
$1.21K
MILLER RICHARD A MD
11 Jun 2019
President and CEO
Buy indirect
6,000
$3.67
$22.02K
LEA LEIV
7 Jun 2019
Chief Financial Officer
Buy indirect
10,000
$3.38
$33.80K
MILLER RICHARD A MD
7 Jun 2019
President and CEO
Buy indirect
9,212
$3.37
$31.02K
LEA LEIV
6 Jun 2019
Chief Financial Officer
Buy indirect
15,500
$3.56
$55.18K
MILLER RICHARD A MD
27 Dec 2018
President and CEO
Buy indirect
20,000
$3.29
$65.88K
LEA LEIV
21 Dec 2018
Chief Financial Officer
Buy indirect
24,700
$4.15
$102.41K
MILLER RICHARD A MD
20 Dec 2018
President and CEO
Buy indirect
5,000
$4.39
$21.95K
MILLER RICHARD A MD
20 Dec 2018
President and CEO
Buy indirect
5,000
$4.40
$22.00K
MILLER RICHARD A MD
6 Dec 2018
President and CEO
Buy indirect
5,000
$5.99
$29.93K
MILLER RICHARD A MD
4 Dec 2018
President and CEO
Buy indirect
1,502
$5.95
$8.94K
MILLER RICHARD A MD
12 Mar 2018
President and CEO
Buy indirect
100,000
$8.50
$850.00K
ADAMS STREET PARTNERS LLC
12 Mar 2018
10% owner
Buy indirect
126,806
$8.50
$1.08M
ADAMS STREET PARTNERS LLC
12 Mar 2018
10% owner
Buy indirect
87,668
$8.50
$745.18K
ADAMS STREET PARTNERS LLC
12 Mar 2018
10% owner
Buy indirect
67,769
$8.50
$576.04K
ADAMS STREET PARTNERS LLC
12 Mar 2018
10% owner
Buy indirect
236,128
$8.50
$2.01M
ADAMS STREET PARTNERS LLC
12 Mar 2018
10% owner
Buy indirect
69,864
$8.50
$593.84K
Gould Terry P
12 Mar 2018
Director
Buy indirect
126,806
$8.50
$1.08M
Gould Terry P
12 Mar 2018
Director
Buy indirect
87,668
$8.50
$745.18K
Gould Terry P
12 Mar 2018
Director
Buy indirect
67,769
$8.50
$576.04K
Gould Terry P
12 Mar 2018
Director
Buy indirect
236,128
$8.50
$2.01M
Gould Terry P
12 Mar 2018
Director
Buy indirect
69,864
$8.50
$593.84K
Novo Holdings A/S
12 Mar 2018
10% owner
Buy
1,176,470
$8.50
$10.00M
ORBIMED ADVISORS LLC
12 Mar 2018
Director
Buy indirect
588,235
$8.50
$5.00M
Thompson Peter A.
12 Mar 2018
Director
Buy indirect
588,235
$8.50
$5.00M
MILLER RICHARD A MD
20 Nov 2017
President and CEO
Buy indirect
10,000
$10.79
$107.85K
Novo Holdings A/S
23 Jun 2017
10% owner
Buy
20,000
$10.95
$219.00K
MILLER RICHARD A MD
13 Jun 2017
President and CEO
Buy indirect
2,500
$10.14
$25.35K
MILLER RICHARD A MD
13 Jun 2017
President and CEO
Buy indirect
2,500
$9.75
$24.38K
MILLER RICHARD A MD
12 Jun 2017
President and CEO
Buy indirect
11,216
$9.82
$110.18K
MILLER RICHARD A MD
9 Jun 2017
President and CEO
Buy indirect
3,784
$9.89
$37.42K
MILLER RICHARD A MD
9 Jun 2017
President and CEO
Buy indirect
5,000
$9.95
$49.75K

What was left out

Form 4 filings counted 194
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 3,905,814
Sales filed before the plan box existed 9
History held since 8 Dec 2016